CARSgen Therapeutics has claimed approval in China, its home market, for satricabtagene autoleucel (satri-cel), said to be ...

Genpact and analyst firm HFS Research have published a new global study, ‘The $18 Trillion Opportunity: How Four Enterprise ...

In the first piece of news from the BIO conference that gets underway in San Diego today, Insilico Medicine has teamed up ...

Paulo Fontoura, currently chief medical officer of Xaira Therapeutics, will replace Houman Ashrafian as Sanofi's R&D head on 1st September. The R&D baton at Sanofi will soon be handed over, as the ...

The first generic alternative to Roche's oral drug for influenza, Xofluza, has been approved by the FDA and should be ...

The FDA refused to accept uniQure's filing for AMT-130 last November, and earlier this year the Dutch biotech said it had ...

Details are starting to emerge of last week's cyberattack on Novo Nordisk, which now appears to have been a $25 million ...

At ASCO 2026 in Chicago, Pedro Valencia, vice president of asset strategy leadership for oncology at AbbVie, joined ...

As such, Google AI Overviews represent a major shift in search for the pharma industry, moving from traditional link-based ...

AI company Anthropic has launched a new large language model (LLM) – Claude Fable 5 – claiming its capabilities as a tool for ...

Capvaxive, which covers 21 strains of Streptococcus pneumoniae, has been approved since 2024 for the prevention of invasive ...

Men with a particular form of prostate cancer now have a targeted treatment for the first time, thanks to FDA approval of a ...